11-22274548-CTTTTT-CTT
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6_Very_StrongBS2_Supporting
The NM_213599.3(ANO5):c.2236-12_2236-10delTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000458 in 1,267,016 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000048 ( 0 hom. )
Consequence
ANO5
NM_213599.3 intron
NM_213599.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.693
Genes affected
ANO5 (HGNC:27337): (anoctamin 5) This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 11-22274548-CTTT-C is Benign according to our data. Variant chr11-22274548-CTTT-C is described in ClinVar as [Benign]. Clinvar id is 499548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-22274548-CTTT-C is described in Lovd as [Likely_benign].
BS2
High AC in GnomAdExome4 at 54 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANO5 | NM_213599.3 | c.2236-12_2236-10delTTT | intron_variant | ENST00000324559.9 | NP_998764.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANO5 | ENST00000324559.9 | c.2236-12_2236-10delTTT | intron_variant | 1 | NM_213599.3 | ENSP00000315371.9 |
Frequencies
GnomAD3 genomes AF: 0.0000272 AC: 4AN: 147070Hom.: 0 Cov.: 27
GnomAD3 genomes
AF:
AC:
4
AN:
147070
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000695 AC: 8AN: 115060Hom.: 0 AF XY: 0.0000807 AC XY: 5AN XY: 61940
GnomAD3 exomes
AF:
AC:
8
AN:
115060
Hom.:
AF XY:
AC XY:
5
AN XY:
61940
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000482 AC: 54AN: 1119946Hom.: 0 AF XY: 0.0000398 AC XY: 22AN XY: 553356
GnomAD4 exome
AF:
AC:
54
AN:
1119946
Hom.:
AF XY:
AC XY:
22
AN XY:
553356
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000272 AC: 4AN: 147070Hom.: 0 Cov.: 27 AF XY: 0.0000279 AC XY: 2AN XY: 71620
GnomAD4 genome
AF:
AC:
4
AN:
147070
Hom.:
Cov.:
27
AF XY:
AC XY:
2
AN XY:
71620
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Miyoshi muscular dystrophy 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 30, 2016 | - - |
Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | - - |
Gnathodiaphyseal dysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at